A consumer smartwatch worn on the wrist correctly identifies moderate-to-severe obstructive sleep apnea 94 percent of the time, according to new research published in the Journal of Clinical Sleep Medicine. Led by investigators at Stanford University, the study tested the Samsung Galaxy Watch on 147 adults to evaluate its potential as an accessible first-line screening tool for a dangerous and vastly underdiagnosed sleep disorder.
Decoding the Clinical Implications of Wearable Sleep Screening
Obstructive sleep apnea is a frequent and perilous medical issue wherein a person’s breathing continually pauses or becomes limited during rest because the upper airway narrows or collapses. Untreated, the repetitive cycles of oxygen deprivation and abrupt arousal place sustained strain on the cardiovascular system. According to the American Academy of Sleep Medicine, this chronic physiologic stress is associated with an elevated risk of stroke, heart attacks, depression, and motor vehicle accidents.
The clinical trial involved 147 adults with an average age of 54 years. Participants either carried a prior diagnosis of moderate-to-severe sleep apnea or were evaluated as having a high pre-test probability for the condition. Volunteers wore a Samsung Galaxy Watch 6 for two nights during laboratory polysomnography—the gold-standard diagnostic test that records brain waves, breathing effort, oxygen saturation, and muscle activity—at the Stanford Health Care Sleep Medicine Center, followed by three additional nights at home.
At its default setting, the watch achieved 94 percent sensitivity and 67 percent specificity. In clinical terms, sensitivity measures how reliably a device catches people who truly have the condition, while specificity measures how well it avoids falsely flagging healthy individuals. A high-sensitivity screening tool is ideal for the front door of a diagnostic pathway because it rarely misses a genuine case.
Algorithmic Performance Across High-Risk Hypoxic Burdens
Performance improved even further among high-risk individuals exhibiting an elevated hypoxic burden. In this specific subgroup, the device achieved 100 percent sensitivity and 100 percent specificity. Hypoxic burden quantifies how severely and how frequently blood oxygen saturation drops during sleep, capturing the actual physiological stress imposed by repetitive airway collapses rather than merely counting respiratory events.
Principal investigator Dr. Robson Capasso, professor of otolaryngology, head and neck surgery, at Stanford University, noted that consumer smartwatches can broaden access to early risk identification. Our findings show that consumer smartwatches can make sleep apnea screening more accessible by identifying people at risk for moderate-to-severe obstructive sleep apnea,
Capasso stated. He emphasized that these devices are not diagnostic instruments, but rather triage tools designed to shorten the path to clinical evaluation and established therapies like positive airway pressure and weight management.
Lead author Arash Alavi, director of software engineering at Stanford University’s Deep Data Research Center, highlighted the importance of multi-night validation. One of the important aspects of this study is that we validated the smartwatch across multiple nights and multiple sleep apnea measures, including apnea-hypopnea index and hypoxic burden,
Alavi explained. Testing the algorithm across both laboratory and home environments captured the night-to-night physiological variability inherent to real-world sleep patterns.
Contraindications & When to Consult a Doctor
Wearable screening devices are not intended to replace formal polysomnography or serve as standalone diagnostic tools. Anyone experiencing classic symptoms of obstructive sleep apnea—such as habitual loud snoring, witnessed gasping or choking episodes during sleep, or excessive daytime somnolence—should seek formal medical evaluation through a primary care physician or an accredited sleep center, regardless of whether a consumer wearable flags an abnormality.
| Metric / Parameter | Study Group Default Setting | High-Risk Hypoxic Burden Subgroup |
|---|---|---|
| Sample Size (N) | 147 Adults (Average Age: 54) | Subset with Elevated Hypoxic Burden |
| Sensitivity | 94% | 100% |
| Specificity | 67% | 100% |
References
- Capasso, R., et al. Smartwatch-based detection of moderate-to-severe and high-risk obstructive sleep apnea. Journal of Clinical Sleep Medicine.
- American Academy of Sleep Medicine. (n.d.). Study finds a smartwatch can help screen for obstructive sleep apnea.
